Innovation

Modulators of Nitric Oxide Signaling for the Stimulation Hematopoietic Stem Cells

Children's Hospital Boston
posted on 07/01/2010

Dr. Zon's Lab has discovered that nitric oxide (NO) signaling is a conserved regulator of hematopoietic stem cell (HSC) development. During embryogenesis in both zebafish and mammals, the initial generation of blood flow is required in order to induce a NO-mediated stimulation of HSC proliferation and differentiation. Screening for chemical modulators of HSC proliferation, the Zon lab as discovered that compounds that stimulate NO generation or NO pathway response can enhance the proliferation of HSCs. This work provides a platform for the identification and testing of compounds for the stimulation of HSC proliferation and engraftment. Initial chemical hits provide leads for the development of novel therapeutics and new uses for existing pharmaceutics for HCS transplants.


Innovation Details
 

File Number: CMCC 1720 

Other Information: *Investigator(s)*
Leonard I Zon

*Contact*
Abbie Meyer, Abbie.Meyer@childrens.harvard.edu


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact David Altman at Children's Hospital Boston for more information.

Request more info via email request more info
People

Case Manager:

David Altman David Altman

Innovations (0)


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Profile
Related Tags

Find more innovations


February 11, 2009

7,868 members 17,196 innovations 152 organizations

Browse

David Kolb, CEO and chairman of the board, Emunamedica LLC.

"We found tremendous value and benefit in using the iBridge Network..."  read more...